Comparing Ajovy vs Qulipta
| Ajovy (fremanezumab) | Qulipta (atogepant) |
|
|---|
| Ajovy (fremanezumab) | Qulipta (atogepant) |
|
|||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Prescription only
Ajovy is used to prevent migraines in adults and to prevent episodic migraine in children aged 6 to 17 years of age and who weigh 45 kg (99 lb) or more. It can be self-injected under the skin once a... View more |
Prescription only
Prescribed for Chronic Migraine, Migraine Prevention. Qulipta may also be used for purposes not listed in this medication guide. |
Related suggestions Migraine Prevention (Migraine Prophylaxis)
Popular comparisons
|
|||||||||||||||
| More about Ajovy (fremanezumab) | More about Qulipta (atogepant) | ||||||||||||||||
| Ratings & Reviews | |||||||||||||||||
|
Ajovy has an average rating of 5.6 out of 10 from a total of 346 ratings on Drugs.com. 40% of reviewers reported a positive effect, while 39% reported a negative effect. |
Qulipta has an average rating of 8.1 out of 10 from a total of 189 ratings on Drugs.com. 72% of reviewers reported a positive effect, while 7% reported a negative effect. |
||||||||||||||||
| Side Effects Experienced by Users Side effects are reported in Drugs.com user reviews and not clinically verified. | |||||||||||||||||
View all Ajovy side effects |
View all Qulipta side effects |
||||||||||||||||
| Drug Class | |||||||||||||||||
| Generic Availability | |||||||||||||||||
|
N/A |
|||||||||||||||||
| Pricing and Coupons * Prices are without insurance | |||||||||||||||||
View all Ajovy prices |
View all Qulipta prices |
||||||||||||||||
| Dosage Forms | |||||||||||||||||
|
|
||||||||||||||||
| Brand Names | |||||||||||||||||
|
N/A |
N/A |
||||||||||||||||
| Half Life Drug half-life is the time required for plasma concentration to reduce to half its original value. | |||||||||||||||||
|
744 hours |
11 hours |
||||||||||||||||
| CSA Schedule 1 View glossary of CSA terms | |||||||||||||||||
|
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||||||||||
| Pregnancy Category | |||||||||||||||||
|
Summary unavailable. See the full pregnancy warnings document. |
Summary unavailable. See the full pregnancy warnings document. |
||||||||||||||||
| Drug Interactions | |||||||||||||||||
|
A total of 3 drugs are known to interact with Ajovy:
|
A total of 196 drugs are known to interact with Qulipta:
|
||||||||||||||||
| Alcohol/Food/Lifestyle Interactions | |||||||||||||||||
|
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
||||||||||||||||
| Disease Interactions | |||||||||||||||||
|
No known disease interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
|||||||||||||||||
| First Approval Date | |||||||||||||||||
|
September 14, 2018 |
September 28, 2021 |
||||||||||||||||
| WADA Class View classifications | |||||||||||||||||
|
N/A |
N/A |
||||||||||||||||
| More Information | |||||||||||||||||
| Patient Resources | |||||||||||||||||
| Professional Resources | |||||||||||||||||
| Related Treatment Guide | |||||||||||||||||
1 The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
See also:
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.